Monthly Archives: March 2018

28 March 2018

Inflowmatix – Parkwalk closes investment

By |March 28th, 2018|

We are delighted to announce that the Parkwalk Opportunities Fund has participated in a funding round for Inflowmatix, an Imperial College spin-out company providing high-resolution sensors and associated analytics initially to the water industry.

Their technology will enable clients to actively manage their asset base through risk-based preventative maintenance and ultimately dynamic network optimisation.

Oxford Endovascular – Parkwalk and UOIF IV investment

By |March 28th, 2018|

We have recently closed an investment in Oxford Endovascular for the Parkwalk Opportunities EIS Fund and the University of Oxford Innovation Fund IV.

Oxford Endovascular have developed Oxiflow, a novel, next generation ‘flow-diverter’ that diverts blood flow away from intracranial aneurysms at risk of rupture. The device is a metallic mesh tube, laser cut from Nitinol […]

Cambridge Touch Technologies – UCEF V and Opportunities Fund investment

By |March 26th, 2018|

We have recently closed an investment in Cambridge Touch Technologies for the University of Cambridge Enterprise Fund V and the Parkwalk Opportunities Fund.

CTT spun-out of the Centre for Advanced Photonics and Engineering (CAPE) at the University of Cambridge. The technology has been developed in collaboration with the laboratory of Professor Arokia Nathan with whom the […]

Oxford Flow – Parkwalk closes Investment

By |March 20th, 2018|

We are delighted to announce that the Parkwalk Opportunities EIS Fund has completed an investment in Oxford Flow, an Oxford University spin-out company developing and manufacturing innovative pressure control equipment.

Oxford Flow has arisen from the work of Professor Tom Povey, of the university’s Osney Thermo-Fluids Laboratory and particularly from his studies on Pressure Regulator […]

MediaGamma – Parkwalk closes Investment

By |March 15th, 2018|

We are delighted to announce that Parkwalk and the UCL Technology Fund have co-led a £2m funding of MediaGamma, a UCL Business spin-out developing  predictive analytics software.

The company has developed a world leading enterprise-grade reinforcement machine learning (self-learning) platform, delivering decisions in under five milliseconds. It has proven its technology in programmatic advertising, building and training […]

Brainomix – Parkwalk closes follow-on investment

By |March 7th, 2018|

We have recently closed an investment in Brainomix for the Parkwalk Opportunities EIS Fund and the University of Oxford Innovation Fund IV.

Brainomix, the medical imaging company using artificial intelligence (AI) for the fast diagnosis and treatment of stroke victims, has closed a £7m ($9.8m) funding roundt to bring its software to the global healthcare market.

Parkwalk lead […]